Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Spyre Therapeutics Inc. (NASDAQ : SYRE) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.
Quote
| Last: | $72.625 |
|---|---|
| Change Percent: | 5.1% |
| Open: | $70.325 |
| Close: | $69.10 |
| High: | $76.105 |
| Low: | $69.815 |
| Volume: | 345,266 |
| Last Trade Date Time: | 06/03/2026 10:34:50 am |
Stock Data
| Market Cap: | $2,603,991,883 |
|---|---|
| Float: | 65,619,664 |
| Insiders Ownership: | 1.61% |
| Institutions: | 44 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.spyre.com |
| Country: | US |
| City: | Waltham |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Spyre Therapeutics Inc. (NASDAQ: SYRE).
